Traumatic vascular injuries represent a critical challenge in both civilian and military settings. They can result from blunt forces, penetrating wounds (including gunshot and blast injuries) or ...
Humacyte, Inc. has announced that the FDA has granted full approval for SYMVESS, a novel bioengineered human tissue designed for use as a vascular conduit in patients with extremity arterial injuries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results